UMIN000051180Completed
The change in FIB-4 in Japanese patients with type 2 diabetes treated by a fixed-ratio combination therapy of insulin degludec and liraglutide (IDegLira)
Edogawa HospitalUniversity Hospital Medical Information Network
VerifiedUniversity Hospital Medical Information Network
Study focus
- Disease/Condition
- Type 2 diabetes mellitus
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Edogawa Hospital
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Dec 01, 2020
- End date
- N/A
ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with multiple complications
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000051180
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000051180 through Pure Global AI's free database. This phase not specified trial is sponsored by Edogawa Hospital and is currently Completed. The study focuses on Type 2 diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.